Loading company details...
Beta
Latest Form 4 (Jul 18, 2024): William Valle (Director): Grant/Award of 5,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 18, 2024 | William Valle | Grant/Award | 5,000 | n/a |
| Jul 18, 2024 | Bradley M. Fluegel | Grant/Award | 5,000 | n/a |
| Jul 18, 2024 | Stephen Divers, Chief Medical Officer | Grant/Award | 36,000 | n/a |
| Jul 18, 2024 | Erica Mallon, General Counsel | Grant/Award | 36,000 | n/a |
| Jul 18, 2024 | David Afshar, Chief Financial Officer | Grant/Award | 150,000 | n/a |
| Jul 18, 2024 | Todd Schonherz, Chief Executive Officer | Grant/Award | 300,000 | n/a |
| May 30, 2024 | Stephen Divers, Chief Medical Officer | Purchase | 5,000 | $10.8K |
| May 30, 2024 | Todd Schonherz, Chief Executive Officer | Purchase | 4,000 | $7.5K |
| May 7, 2024 | Bradley M. Fluegel | Grant/Award | 14,981 | n/a |
| May 7, 2024 | William Valle | Grant/Award | 14,981 | n/a |